Benjamin Edwards Inc. Reduces Stake in iShares Biotechnology ETF $IBB

Benjamin Edwards Inc. lowered its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 79.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,231 shares of the financial services provider’s stock after selling 12,654 shares during the quarter. Benjamin Edwards Inc.’s holdings in iShares Biotechnology ETF were worth $614,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in IBB. Pension & Wealth Management Advisors Inc. bought a new stake in shares of iShares Biotechnology ETF during the second quarter valued at about $28,000. Basepoint Wealth LLC bought a new position in shares of iShares Biotechnology ETF in the fourth quarter valued at approximately $26,000. Cary Street Partners Financial LLC bought a new position in shares of iShares Biotechnology ETF in the fourth quarter valued at approximately $29,000. Darwin Wealth Management LLC purchased a new position in iShares Biotechnology ETF during the second quarter valued at approximately $25,000. Finally, Caitlin John LLC purchased a new position in iShares Biotechnology ETF during the fourth quarter valued at approximately $34,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 1.4%

iShares Biotechnology ETF stock opened at $213.80 on Thursday. The firm’s 50 day simple moving average is $196.95 and its 200 day simple moving average is $179.74. iShares Biotechnology ETF has a 1-year low of $138.79 and a 1-year high of $217.12.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Monday, June 15th were given a dividend of $0.0238 per share. This represents a $0.10 dividend on an annualized basis and a dividend yield of 0.0%. The ex-dividend date was Monday, June 15th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.